Interferon-alpha: Clinical Trials

4 trials of Interferon-alpha, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 withdrawn. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Withdrawn 4
Phase 11Withdrawn 1

Follow Interferon-alpha: new trials by email Literature Review of Interferon-alpha trials Research Report on Interferon-alpha

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma.
Autologous dendritic cells generated using GM-CSF, interferon alpha and LPS - Lymphoma
Phase 1 / Phase 2WithdrawnBaylor Research Institute2008-07-012017-06-12
Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma
recombinant interferon alfa, rituximab, cyclophosphamide - Lymphoma
Phase 2WithdrawnHoag Memorial Hospital Presbyterian1998-06-012015-08-19
Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy
recombinant interferon alfa, rituximab - Leukemia, Multiple Myeloma and Plasma Cell Neoplasm
Phase 2WithdrawnHoag Memorial Hospital Presbyterian1998-06-012015-08-19
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
recombinant interferon alfa, amifostine trihydrate, bromodeoxyuridine - Leukemia
Phase 2WithdrawnRush University Medical Center1998-04-012021-10-14

Conditions studied

Leukemia (2)  ·  Lymphoma (2)  ·  Burkitt Lymphoma (1)  ·  Leukemia, Erythroblastic, Acute (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Megakaryoblastic, Acute (1)  ·  Leukemia, Monocytic, Acute (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myelomonocytic, Acute (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Large-Cell, Immunoblastic (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Multiple Myeloma (1)

Sponsors

Hoag Memorial Hospital Presbyterian (2)  ·  Baylor Research Institute (1)  ·  Rush University Medical Center (1)

Countries

United States (3)

Top investigators

Robert O. Dillman, MD, FACP (2)  ·  Karolina Palucka, MD, PhD (1)  ·  Philip D. Bonomi, MD (1)

NIH funding

P01CA075606 (1)